Literature DB >> 23303844

Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis.

Makito Hirano1, Yusaku Nakamura, Kazumasa Saigoh, Hikaru Sakamoto, Shuichi Ueno, Chiharu Isono, Katsuichi Miyamoto, Maiko Akamatsu, Yoshiyuki Mitsui, Susumu Kusunoki.   

Abstract

OBJECTIVE: The purpose of this study was to find mutations in the SQSTM1 gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis (ALS), since this gene has been recently identified as a causative gene for familial and sporadic ALS in the United States.
METHODS: We sequenced this gene in 61 Japanese patients with sporadic and familial ALS. To our knowledge, we describe for the first time the clinical information of such mutation-positive patients.
RESULTS: We found novel mutations, p.Ala53Thr and p.Pro439Leu, in 2 patients with sporadic ALS. The clinical picture of the mutation-positive patients was that of typical ALS with varied upper motor neuron signs. Although this gene is causative for another disease, Paget disease of bone (PDB), none of our patients showed evidence of concomitant PDB.
CONCLUSION: The presence of mutations in this racial population suggests worldwide, common involvement of the SQSTM1 gene in ALS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23303844     DOI: 10.1212/WNL.0b013e31827f0fe5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

Review 1.  Autophagy and human diseases.

Authors:  Peidu Jiang; Noboru Mizushima
Journal:  Cell Res       Date:  2013-12-10       Impact factor: 25.617

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons.

Authors:  Disi An; Ryosuke Fujiki; Dylan E Iannitelli; John W Smerdon; Shuvadeep Maity; Matthew F Rose; Alon Gelber; Elizabeth K Wanaselja; Ilona Yagudayeva; Joun Y Lee; Christine Vogel; Hynek Wichterle; Elizabeth C Engle; Esteban Orlando Mazzoni
Journal:  Elife       Date:  2019-06-03       Impact factor: 8.140

4.  Wildtype sigma-1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.

Authors:  Yasuharu Shinoda; Yudai Haga; Koichiro Akagawa; Kohji Fukunaga
Journal:  J Biol Chem       Date:  2020-10-14       Impact factor: 5.157

5.  Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.

Authors:  Katrina J Llewellyn; Angèle Nalbandian; Kwang-Mook Jung; Christopher Nguyen; Agnesa Avanesian; Tahseen Mozaffar; Daniele Piomelli; Virginia E Kimonis
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

Review 6.  Autophagy and neurodegeneration.

Authors:  Rebecca A Frake; Thomas Ricketts; Fiona M Menzies; David C Rubinsztein
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

7.  Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research.

Authors:  Peihao Fan; Nanyi Wang; Lirong Wang
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

8.  A novel small molecule HSP90 inhibitor, NXD30001, differentially induces heat shock proteins in nervous tissue in culture and in vivo.

Authors:  Jieun R C Cha; Kyle J H St Louis; Miranda L Tradewell; Benoit J Gentil; Sandra Minotti; Zahara M Jaffer; Ruihong Chen; Allan E Rubenstein; Heather D Durham
Journal:  Cell Stress Chaperones       Date:  2013-10-03       Impact factor: 3.667

9.  Autophagy in Myelinating Glia.

Authors:  Jillian Belgrad; Raffaella De Pace; R Douglas Fields
Journal:  J Neurosci       Date:  2019-11-19       Impact factor: 6.167

10.  Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB.

Authors:  Chun T Kwok; Alex Morris; Jacqueline S de Belleroche
Journal:  Eur J Hum Genet       Date:  2013-08-14       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.